文献速递角膜与眼表疾病

单纯疱疹性角膜炎时间进程转录组分析揭示PANoptosis-CCL2轴

Time-Course Transcriptomic Analysis Reveals PANoptosis-CCL2 Axis in Herpes Simplex Keratitis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该研究通过小鼠HSV-1感染模型和时间序列RNA测序,揭示了角膜免疫应答的时序阶段及PANoptosis在HSK发病中的核心作用。ZBP1驱动的PANoptosome形成促进PANoptosis,进而通过CCL2/CCR2轴增强巨噬细胞MHC-II和IFN-β表达与迁移,该轴可被PANoptosis抑制剂或CCL2拮抗剂Bindarit抑制。

要点

  • HSK角膜免疫应答分三阶段:0-3天稳态破坏与转录激活,3-7天免疫放大,7-14天组织重塑。
  • PANoptosis在免疫放大阶段激活,ZBP1是PANoptosome形成的关键驱动因子。
  • PANoptosis-CCL2/CCR2轴可被PANoptosis抑制剂或CCL2拮抗剂Bindarit抑制。

核心结论

  • HSK中免疫激活与PANoptosis存在时序协调,PANoptosis是放大抗病毒免疫应答的关键机制。
  • ZBP1-PANoptosome介导的PANoptosis-CCL2/CCR2轴是调节HSK免疫应答的潜在治疗靶点。

研究设计与样本

  • 建立小鼠HSV-1感染HSK模型,于感染后0、1、3、7、14天进行时间序列RNA测序。
  • 采用qRT-PCR、蛋白质印迹、免疫荧光染色、流式细胞术和共培养实验进行表型与机制分析。
  • 使用靶向PANoptosis的拮抗剂评估程序性细胞死亡通路。

主要发现

  • RNA测序揭示角膜HSV-1感染后免疫应答分三个时序阶段:0-3天稳态破坏与转录激活,3-7天免疫放大,7-14天组织重塑。
  • 免疫放大阶段与凋亡、焦亡和坏死性凋亡三条程序性细胞死亡通路激活密切相关,最终汇聚为PANoptosis。
  • PANoptosis被证实为HSK发病的核心机制,ZBP1是PANoptosome形成的关键驱动因子。
  • 人角膜上皮细胞中PANoptosis促进CCL2释放,增强巨噬细胞MHC-II和IFN-β表达及迁移。
  • PANoptosis-CCL2/CCR2轴在感染角膜中显著上调,可被PANoptosis抑制剂或CCL2拮抗剂Bindarit抑制。

临床怎么用

  • PANoptosis-CCL2/CCR2轴可作为HSK免疫调节的潜在治疗靶点。
  • PANoptosis抑制剂或CCL2拮抗剂Bindarit可能用于抑制HSK中的免疫放大阶段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to characterize the temporal dynamics of corneal immune responses and programmed cell death (PCD) following herpes simplex virus type 1 (HSV-1) infection, and investigate the role of PANoptosis in shaping the immune responses during herpes simplex keratitis (HSK). METHODS: A murine HSK model was established through HSV-1 infection, and time-course RNA sequencing was performed on murine corneas at 0, 1, 3, 7, and 14 days post-infection. Phenotypic and mechanistic analyses were conducted using quantitative real-time PCR, western blotting, immunofluorescence staining, flow cytometry, and co-culture experiments. PCD pathways were assessed using antagonists targeting PANoptosis, an integrated form of cell death encompassing key features of apoptosis, pyroptosis, and necroptosis. RESULTS: RNA sequencing revealed sequential immune response phases in the cornea following HSV-1 infection: homeostasis disruption and transcriptional activation (0-3 days), immune amplification (3-7 days), and tissue reorganization (7-14 days). The immune amplification phase was strongly associated with the activation of three distinct PCD pathways: apoptosis, pyroptosis, and necroptosis, culminating in PANoptosis. PANoptosis was confirmed as a central mechanism in HSK pathogenesis, with Z-DNA-binding protein 1 (ZBP1) serving as a key driver of PANoptosome formation. Furthermore, PANoptosis in human corneal epithelial cells (HCECs) was shown to promote the release of C-C motif chemokine ligand 2 (CCL2), enhancing macrophage major histocompatibility complex class II (MHC-II) and interferon β (IFN-β) expression and migration. The PANoptosis-CCL2/C-C motif chemokine receptor 2 (CCR2) axis was significantly upregulated in infected corneas and could be suppressed by a PANoptosis inhibitor or the CCL2 antagonist Bindarit. CONCLUSIONS: This study demonstrated the temporal coordination between immune activation and PANoptosis in HSK, highlighting PANoptosis as a crucial mechanism in amplifying antiviral immune responses. The ZBP1-PANoptosome-mediated PANoptosis-CCL2/CCR2 axis represents a potential therapeutic target for modulating the immune responses in HSK.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Wu C, Ouyang J, Liu Y, et al. Time-Course Transcriptomic Analysis Reveals PANoptosis-CCL2 Axis in Herpes Simplex Keratitis. Invest Ophthalmol Vis Sci. 2026. PMID: 42312921. doi:10.1167/iovs.67.6.38

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。